147 related articles for article (PubMed ID: 28412709)
21. Work instability and financial loss in early inflammatory arthritis.
Looper KJ; Mustafa SS; Zelkowitz P; Purden M; Baron M;
Int J Rheum Dis; 2012 Dec; 15(6):546-53. PubMed ID: 23253238
[TBL] [Abstract][Full Text] [Related]
22. Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis.
Allaire S; Wolfe F; Niu J; Lavalley M; Michaud K
Arthritis Rheum; 2005 Aug; 53(4):603-8. PubMed ID: 16082625
[TBL] [Abstract][Full Text] [Related]
23. Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis.
Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Korpela M; Leirisalo-Repo M; Luukkainen R; Puolakka K; Karjalainen A; Sokka T
J Rheumatol; 2007 Oct; 34(10):1987-91. PubMed ID: 17611990
[TBL] [Abstract][Full Text] [Related]
24. Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.
Salaffi F; Stancati A; Neri R; Grassi W; Bombardieri S
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S31-42. PubMed ID: 16273783
[TBL] [Abstract][Full Text] [Related]
25. Sick leave and work disability in patients with early arthritis.
Zirkzee EJ; Sneep AC; de Buck PD; Allaart CF; Peeters AJ; Ronday HK; Westedt ML; le Cessie S; Vliet Vlieland TP
Clin Rheumatol; 2008 Jan; 27(1):11-9. PubMed ID: 17492248
[TBL] [Abstract][Full Text] [Related]
26. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
27. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
[TBL] [Abstract][Full Text] [Related]
28. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis.
Olofsson T; Söderling JK; Gülfe A; Kristensen LE; Wallman JK
Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1712-1716. PubMed ID: 29885037
[TBL] [Abstract][Full Text] [Related]
29. Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register.
Odegård S; Finset A; Kvien TK; Mowinckel P; Uhlig T
Scand J Rheumatol; 2005; 34(6):441-7. PubMed ID: 16393765
[TBL] [Abstract][Full Text] [Related]
30. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
Ruban TN; Jacob B; Pope JE; Keystone EC; Bombardier C; Kuriya B
Clin Rheumatol; 2016 Mar; 35(3):759-63. PubMed ID: 26245721
[TBL] [Abstract][Full Text] [Related]
31. Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States.
Sullivan PW; Ghushchyan V; Huang XY; Globe DR
J Rheumatol; 2010 Mar; 37(3):544-9. PubMed ID: 20080920
[TBL] [Abstract][Full Text] [Related]
32. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.
Walker N; Michaud K; Wolfe F
J Rheumatol; 2005 Jun; 32(6):1006-12. PubMed ID: 15940759
[TBL] [Abstract][Full Text] [Related]
33. An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis.
Macedo A; Oakley S; Gullick N; Kirkham B
J Rheumatol; 2009 Feb; 36(2):225-30. PubMed ID: 19208557
[TBL] [Abstract][Full Text] [Related]
34. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
Zhu TY; Tam LS; Li EK
Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and ultrasound assessment of the disease activity in patients with rheumatoid arthritis].
Targońska-Stępniak B; Piotrowski M; Zwolak R; Majdan M
Wiad Lek; 2016; 69(4):616-620. PubMed ID: 27941198
[TBL] [Abstract][Full Text] [Related]
36. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
[TBL] [Abstract][Full Text] [Related]
37. Longterm Work Productivity Costs Due to Absenteeism and Permanent Work Disability in Patients with Early Rheumatoid Arthritis: A Nationwide Register Study of 7831 Patients.
Martikainen JA; Kautiainen H; Rantalaiho V; Puolakka KT
J Rheumatol; 2016 Dec; 43(12):2101-2105. PubMed ID: 27909140
[TBL] [Abstract][Full Text] [Related]
38. Multidimensional Model of Disability and Role Functioning in Rheumatoid Arthritis.
Ormseth SR; Draper TL; Irwin MR; Weisman MH; Aréchiga AE; Hartoonian N; Bui T; Nicassio PM
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1686-92. PubMed ID: 26212464
[TBL] [Abstract][Full Text] [Related]
39. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M;
Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801
[TBL] [Abstract][Full Text] [Related]
40. Does disease activity at start of biologic therapy influence work-loss in RA patients?
Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
Rheumatology (Oxford); 2016 Apr; 55(4):729-34. PubMed ID: 26683196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
